You are here

  • Home
  • Archive
  • Volume 30, Issue 2
  • Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

Article metrics

Article menu

Download PDFPDF

Short report
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19
Free

 

Online download statistics by month:

Online download statistics by month: April 2021 to February 2023

AbstractFullPdf
Apr 202185084788
May 202123222435
Jun 2021777715
Jul 2021787019
Aug 2021575623
Sep 2021393714
Oct 2021615729
Nov 20219910031
Dec 20211331338
Jan 202217317313
Feb 202213213210
Mar 20222212198
Apr 20221251257
May 202211111220
Jun 2022898511
Jul 202289897
Aug 202211111015
Sep 20221061068
Oct 202290895
Nov 202280816
Dec 2022959212
Jan 2023989812
Feb 202315515513
Total33013267409